The Ethics of the Pharmaceutical Industry and the Need for a Dual Market System
Journal of Medical Humanities. 1995 Spring; 16(1): 55-68.
In an era of increasing medical costs and cries for health care reform in the United States, the pharmaceutical industry has come under intense scrutiny. Ethical issues are inherent in the pharmaceutical marketplace, and there is a need to address the moral rights and responsibilities of drug manufacturers, consumers, health care professionals, and governmental agents in the production, distribution, regulation, and use of these products. A dual market system protecting individual rights to access and autonomy without placing an undue strain on societal resources would provide an adequate and equitable framework for an ethical pharmaceutical industry.
Accountability; Advertising; Autonomy; Common Good; Drug Industry; Drugs; Economics; Ethics; Financial Support; Government; Government Regulation; Health; Health Care; Health Care Delivery; Health Care Reform; Industry; Moral Obligations; Obligations of Society; Obligations to Society; Patient Care; Patients; Physicians; Private Sector; Public Policy; Public Sector; Pharmaceutical Industry; Regulation; Resource Allocation; Rights; Risks and Benefits; Responsibilities; Uncertainty;
Showing items related by title, author, creator and subject.
The Need for a Transparent, Ethical, and Successful Relationship Between Academic Scientists and the Pharmaceutical Industry: A View of the Group for the Respect of Ethics and Excellence in Science (GREES) Bruyere, O; Kanis, J A; Ibar-Abadie, M-E; Alsayed, N; Brandi, M L; Burlet, N; Cahall, D L; Chines, A; Devogelaer, J-P; Dere, W; Goel, N; Hughes, N; Kaufman, J-M; Korte, S; Mitlak, B H; Niese, D; Rizzoli, R; Rovati, L C; Reginster, J-Y (2010-05)This paper provides recommendations for fair and unbiased relationship between academic scientists and the pharmaceutical industry.